Table 1.
Body weight changes of all experimental groups, before and after 28 days of intervention
| Group | Body weight (g) | |
|---|---|---|
| Initial | Final | |
| NC | 539.67±22.76 | 587.50±23.60*$ |
| DC | 479.00±20.62 | 464.17±16.01# |
| PHZ | 468.00±16.01 | 456.50±39.07*# |
| AE250 | 475.50±23.75 | 460.50±39.14# |
| AE500 | 483.17±17.31 | 464.50±31.50# |
| AE1000 | 463.67±14.40 | 431.50±25.15* |
Groups consisted of normal control (NC), diabetic control (DC), phlorizin 60 mg/kg B.W. (PHZ), and AE at the doses of 250 mg/kg B.W. (AE250), 500 mg/kg B.W. (AE500), and 1000 mg/kg B.W. (AE1000). Data were expressed as mean ± SEM (n = 6). All the data were statistically significant at p < 0.05. *P < 0.05 compared to the initial value using paired t-test. $P < 0.05 compared to DC and #P < 0.05 compared to NC using Dunnett post-hoc test